BMJ Best Practice

参考文献

关键文献

Hanno PM, Erickson D, MOldwin R, et al. Diagnosis and treatment of interstitial cystitis/bladder pain syndrome: AUA guideline amendment. J Urol. 2015;193:1545-1553.

Bogart LM, Berry SH, Clemens JQ. Symptoms of interstitial cystitis, painful bladder syndrome and similar diseases in women: a systematic review. J Urol. 2007;177:450-456. [Erratum in: J Urol. 2007;177:2402.]

European Association of Urology. Guidelines on chronic pelvic pain. 2017. http://uroweb.org/ (last accessed 22 May 2017).

van de Merwe JP, Nordling J, Bouchelouche P, et al. Diagnostic criteria, classification, and nomenclature for painful bladder syndrome/interstitial cystitis: an ESSIC proposal. Eur Urol. 2008;53:60-67.

Porru D, Tinelli C, Gerardini M, et al. Evaluation of urinary and general symptoms and correlation with other clinical parameters in interstitial cystitis patients. Neurourol Urodyn. 2005;24:69-73.

Erickson DR, Tomaszewski JE, Kunselman AR, et al. Do the National Institute of Diabetes and Digestive and Kidney Diseases cystoscopic criteria associate with other clinical and objective features of interstitial cystitis? J Urol. 2005;173:93-97.

Alagiri M, Chottiner S, Ratner V, et al. Interstitial cystitis: unexplained associations with other chronic disease and pain syndromes. Urology. 1997;49(5A suppl):52-57.

参考文章

1.  Hanno PM, Erickson D, MOldwin R, et al. Diagnosis and treatment of interstitial cystitis/bladder pain syndrome: AUA guideline amendment. J Urol. 2015;193:1545-1553.

2.  Bogart LM, Berry SH, Clemens JQ. Symptoms of interstitial cystitis, painful bladder syndrome and similar diseases in women: a systematic review. J Urol. 2007;177:450-456. [Erratum in: J Urol. 2007;177:2402.]

3.  European Association of Urology. Guidelines on chronic pelvic pain. 2017. http://uroweb.org/ (last accessed 22 May 2017).

4.  van de Merwe JP, Nordling J, Bouchelouche P, et al. Diagnostic criteria, classification, and nomenclature for painful bladder syndrome/interstitial cystitis: an ESSIC proposal. Eur Urol. 2008;53:60-67.

5.  Hanno P, Lin A, Nordling J, et al; Bladder Pain Syndrome Committee of the International Consultation on Incontinence. Bladder pain syndrome international consultation on incontinence. Neurourol Urodyn. 2010;29:191-198.

6.  Porru D, Tinelli C, Gerardini M, et al. Evaluation of urinary and general symptoms and correlation with other clinical parameters in interstitial cystitis patients. Neurourol Urodyn. 2005;24:69-73.

7.  Curhan GC, Speizer FE, Hunter DJ, et al. Epidemiology of interstitial cystitis: a population based study. J Urol. 1999;161:549-552.

8.  Sant GR, Hanno PM. Interstitial cystitis: current issues and controversies in diagnosis. Urology. 2001;57(6 suppl 1):82-88.

9.  Clemens JQ, Meenan RT, Rosetti MC, et al. Prevalence and incidence of interstitial cystitis in a managed care population. J Urol. 2005;173:98-102.

10.  Lewi H. Medical therapy in interstitial cystitis: the Essex experience. Urology. 2001;57(6 suppl 1):120.

11.  Close CE, Carr MC, Burns MW, et al. Interstitial cystitis in children. J Urol. 1996;156:860-862.

12.  Erickson DR, Propert KJ. Pregnancy and interstitial cystitis/painful bladder syndrome. Urol Clin North Am. 2007;34:61-69.

13.  Peters KM, Carrico DJ, Diokno AC. Characterization of a clinical cohort of 87 women with interstitial cystitis/painful bladder syndrome. Urology. 2008;71:634-640.

14.  Peters KM, Kalinowski SE, Carrico DJ, et al. Fact or fiction: is abuse prevalent in patients with interstitial cystitis? Results from a community survey and clinic population. J Urol. 2007;178:891-895.

15.  Bullones Rodríguez MÁ, Afari N, Buchwald DS; National Institute of Diabetes and Digestive and Kidney Diseases Working Group on Urological Chronic Pelvic Pain. Evidence for overlap between urological and nonurological unexplained clinical conditions. J Urol. 2013;189(suppl 1):S66-S74.

16.  Shorter B, Leser M, Moldwin RM, et al. Effect of comestibles on symptoms of interstitial cystitis. J Urol. 2007;178:145-152.

17.  Killinger KA, Boura JA, Peters KM. Pain in interstitial cystitis/bladder pain syndrome: do characteristics differ in ulcerative and non-ulcerative subtypes? Int Urogynecol J. 2013;24:1295-1301.

18.  Hillelsohn JH, Rais-Bahrami S, Friedlander JI, et al. Fulguration for Hunner ulcers: long-term clinical outcomes. J Urol. 2012;188:2238-2241.

19.  Erickson DR, Tomaszewski JE, Kunselman AR, et al. Do the National Institute of Diabetes and Digestive and Kidney Diseases cystoscopic criteria associate with other clinical and objective features of interstitial cystitis? J Urol. 2005;173:93-97.

20.  Ottem DP, Teichman JM. What is the value of cystoscopy with hydrodistension for interstitial cystitis? Urology. 2005;66:494-499.

21.  Keay S. Cell signaling in interstitial cystitis/painful bladder syndrome. Cell Signal. 2008;20:2174-2179.

22.  Seth JH, Sahai A, Khan MS, et al. Nerve growth factor (NGF): a potential urinary biomarker for overactive bladder syndrome (OAB)? BJU Int. 2013;111:372-380.

23.  Payne C, Allee T. Goal achievement provides new insights into interstitial cystitis/painful bladder syndrome symptoms and outcomes. Neurourol Urodyn. 2009;28:13-17.

24.  Alagiri M, Chottiner S, Ratner V, et al. Interstitial cystitis: unexplained associations with other chronic disease and pain syndromes. Urology. 1997;49(5A suppl):52-57.

25.  Clemens JQ, Meenan RT, O'Keeffe Rosetti MC, et al. Case-control study of medical comorbidities in women with interstitial cystitis. J Urol. 2008;179:2222-2225.

26.  Peters K, Girdler B, Carrico D, et al. Painful bladder syndrome/interstitial cystitis and vulvodynia: a clinical correlation. Int Urogynecol J Pelvic Floor Dysfunct. 2008;19:665-669.

27.  Yamada T, Sakai N, Murayama T, et al. Two cases of interstitial cystitis complicated with migraine [in Japanese]. Hinyokika Kiyo. 1999;45:61-64.

28.  van de Merwe JP. Interstitial cystitis and systemic autoimmune diseases. Nat Clin Pract Urol. 2007;4:484-491.

29.  Lee J, Doggweiler-Wiygul R, Kim S, et al. Is interstitial cystitis an allergic disorder? A case of interstitial cystitis treated successfully with anti-IgE. Int J Urol. 2006;13:631-634.

30.  Kushner L, Moldwin RM. Efficiency of questionnaires used to screen for interstitial cystitis. J Urol. 2006;176:587-592.

31.  Clemens JQ, Brown SO, Kozloff L, et al. Predictors of symptom severity in patients with chronic prostatitis and interstitial cystitis. J Urol. 2006;175:963-966.

32.  Paulson JD, Delgado M. The relationship between interstitial cystitis and endometriosis in patients with chronic pelvic pain. JSLS. 2007;11:175-181.

33.  Warren JW, Howard FM, Cross RK, et al. Antecedent nonbladder syndromes in case-control study of interstitial cystitis/painful bladder syndrome. Urology. 2009;73:52-57.

34.  American Urological Association. Diagnosis and treatment of interstitial cystitis/bladder pain syndrome. December 2014. https://www.auanet.org (last accessed 22 May 2017).

35.  Cox A, Golda N, Nadeau G, et al. CUA guideline: diagnosis and treatment of interstitial cystitis/bladder pain syndrome. Can Urol Assoc J. 2016;10:E136-E155.

36.  Parsons CL, Dell J, Stanford EJ, et al. Increased prevalence of interstitial cystitis: previously unrecognized urologic and gynaecologic cases identified using a new symptom questionnaire and intravesical potassium sensitivity. Urology. 2002;60:573-578.

37.  O'Leary MP, Sant GR, Fowler FJ Jr, et al. The interstitial cystitis symptom index and problem index. Urology. 1997;49(suppl):58-63.

38.  Propert KJ, Mayer RD, Wang Y, et al. Responsiveness of symptom scales for interstitial cystitis. Urology. 2006;67:55-59.

39.  Geirsson G, Wang YH, Lindstrom S, et al. Traditional acupuncture and electrical stimulation of the posterior tibial nerve: a trial in chronic interstitial cystitis. Scand J Urol Nephrol. 1993;27:67-70.

40.  Hanno PM, Landis JR, Matthews-Cook Y, et al; Interstitial Cystitis Database Study Group. The diagnosis of interstitial cystitis revisited: lessons learned from the National Institutes of Health Interstitial Cystitis Database study. J Urol. 1999;161:553-557.

41.  Nickel JC, Barkin J, Forrest J, et al; Elmiron study group. Randomized, double blind, dose-ranging study of pentosan polysulfate sodium for interstitial cystitis. Urology. 2005;65:654-658.

42.  Nickel JC, Herschorn S, Whitmore KE, et al. Pentosan polysulfate sodium for treatment of interstitial cystitis/bladder pain syndrome: insights from a randomized, double-blind, placebo controlled study. J Urol. 2015;193:857-862.

43.  Amrute KV, Moldwin RM. Pharmacotherapy of interstitial cystitis in women. Womens Health (Lond Engl). 2007;3:63-72.

44.  Theoharides TC, Sant GR. Hydroxyzine therapy for interstitial cystitis. Urology. 1997;49(5A suppl):108-110.

45.  Sant GR, Propert KJ, Hanno PM, et al. A pilot clinical trial of oral pentosan polysulfate and oral hydroxyzine in patients with interstitial cystitis. J Urol. 2003;170:810-815.

46.  Pranikoff K, Constantino G. The use of amitriptyline in patients with urinary frequency and pain. Urology. 1998;51(suppl 5A):179-181.

47.  van Ophoven A, Pokupic S, Heinecke A, et al. A prospective, randomized, placebo controlled, double-blind study of amitriptyline for the treatment of interstitial cystitis. J Urol. 2004;172:533-536.

48.  van Ophoven A, Hertle L. Long term results of amitriptyline treatment for interstitial cystitis. J Urol. 2005;174:1837-1840.

49.  Hansen HC. Interstitial cystitis and the potential role of gabapentin. South Med J. 2000;93:238-242.

50.  Lewis SC, Bhattacharya S, Wu O, et al. Gabapentin for the management of chronic pelvic pain in women (GaPP1): a pilot randomised controlled trial. PLoS One. 2016;11:e0153037.

51.  Sairanen J, Forsell T, Ruutu M. Long-term outcome of patients with interstitial cystitis treated with low dose cyclosporine A. J Urol. 2004;171:2138-2141.

52.  Forrest JB, Payne CK, Erickson DR. Cyclosporine A for refractory interstitial cystitis/bladder pain syndrome: experience of 3 tertiary centers. J Urol. 2012;188:1186-1191.

53.  Faculty of Pain Medicine; British Pain Society; Royal College of Nurses; et al. Core standards for pain management services in the UK. October 2015. http://www.britishpainsociety.org/ (last accessed 22 May 2017).

54.  Nickel JC, Moldwin R, Lee S, et al. Intravesical alkalinized lidocaine (PSD597) offers sustained relief from symptoms of interstitial cystitis and painful bladder syndrome. BJU Int. 2009;103:910-918.

55.  Nomiya A, Naruse T, Niimi A, et al. On- and post-treatment symptom relief by repeated instillations of heparin and alkalized lidocaine in interstitial cystitis. Int J Urol. 2013;20:1118-1122.

56.  Barua JM, Arance I, Angulo JC, et al. A systematic review and meta-analysis on the efficacy of intravesical therapy for bladder pain syndrome/interstitial cystitis. Int Urogynecol J. 2016;27:1137-1147.

57.  Smith CP, Radziszewski P, Borkowski A, et al. Botulinum toxin a has antinociceptive effects in treating interstitial cystitis. Urology. 2004;64:871-875.

58.  Giannantoni A, Costantini E, Di Stasi SM, et al. Botulinum A toxin intravesical injections in the treatment of painful bladder syndrome: a pilot study. Eur Urol. 2006;49:704-709.

59.  Kuo HC, Jiang YH, Tsai YC, et al. Intravesical botulinum toxin-A injections reduce bladder pain of interstitial cystitis/bladder pain syndrome refractory to conventional treatment: a prospective, multicenter, randomized, double-blind, placebo-controlled clinical trial. Neurourol Urodyn. 2016;35:609-614.

60.  Bhide AA, Puccini F, Khullar V, et al. Botulinum neurotoxin type A injection of the pelvic floor muscle in pain due to spasticity: a review of the current literature. Int Urogynecol J. 2013;24:1429-1434.

61.  Peters KM, Konstandt D. Sacral neuromodulation decreases narcotic requirements in refractory interstitial cystitis. BJU Int. 2004;93:777-779.

62.  Peters K, Killinger K, Boguslawski BM, et al. Chronic pudendal neuromodulation: expanding available treatment options for refractory urologic symptoms. Neurourol Urodyn. 2010;29:1267-1271.

63.  Fariello JY, Whitmore K. Sacral neuromodulation stimulation for IC/PBS, chronic pelvic pain, and sexual dysfunction. Int Urogynecol J. 2010;21:1553-1558.

64.  van Balken MR, Vandoninck V, Messelink BJ, et al. Percutaneous tibial nerve stimulation as neuromodulative treatment of chronic pelvic pain. Eur Urol. 2003;43:158-163.

65.  Lee CL, Kuo HC. Intravesical botulinum toxin A injections do not benefit patients with ulcer type interstitial cystitis. Pain Physician. 2013;16:109-116.

66.  Peters KM, Jaeger C, Killinger KA, et al. Cystectomy for ulcerative interstitial cystitis: sequelae and patients' perceptions of improvement. Urology. 2013;82:829-833.

67.  Yang TX, Luo DY, Li H, et al. Is urethrectomy necessary during cystectomy in patients with interstitial cystitis or bladder pain syndrome? Urology. 2016;97:73-79.

68.  Nickel JC, Egerdie B, Davis E, et al. A phase II study of the efficacy and safety of the novel oral SHIP1 activator AQX-1125 in subjects with moderate to severe interstitial cystitis/bladder pain syndrome. J Urol. 2016;196:747-754.

使用此内容应接受我们的免责声明